ClinicalTrials.gov
public full text
Public Domain
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety of Discontinuing Patient Antibiotic Treatment#18637
- Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes#180446
- Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit#291002
- Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient#846726
- Procalcitonin-Guided Antimicrobial Discontinuation#208485
Record · ID 1231207
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive